Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X8ZO
|
|||
| Former ID |
DNC013504
|
|||
| Drug Name |
1-(oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one
|
|||
| Synonyms |
1-OXAZOLO[4,5-B]PYRIDIN-2-YL-1-DODECANONE; 288862-73-7; CHEMBL257307; SCHEMBL3964457; MolPort-009-018-944; HMS3649B18; BDBM50350547; 1312AH; ZINC34803705; AKOS027301548; ACM288862737; SR-01000946699; 1-[1,3]oxazolo[4,5-b]pyridin-2-yldodecan-1-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H26N2O2
|
|||
| Canonical SMILES |
CCCCCCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2
|
|||
| InChI |
1S/C18H26N2O2/c1-2-3-4-5-6-7-8-9-10-12-15(21)18-20-17-16(22-18)13-11-14-19-17/h11,13-14H,2-10,12H2,1H3
|
|||
| InChIKey |
XUWBDQAPIZBSRY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.